“专利牙种植系统是每位患者和牙医的最佳选择”专利-动脉网

“The Patent Dental Implant System is the best choice for every patient and dentist” Patent

Dental Tribune 等信源发布 2024-03-19 16:06



可切换为仅中文







Patent

专利

Tue. 19. March 2024

save

节约

Conducted in collaboration with the Medical University of Graz in Austria, a new independent study followed patients treated with the two-piece Patent Dental Implant System for five to 12 years and found no cases of peri-implantitis—even in patients with compromised health. The study was led by Athens-based implant specialist and researcher Dr Sofia Karapataki.

与奥地利格拉茨医科大学合作进行的一项新的独立研究对使用两件式专利牙科植入系统治疗的患者进行了5至12年的随访，即使在健康受损的患者中也没有发现种植体周围炎的病例。这项研究由雅典植入专家兼研究员索菲亚·卡拉帕塔基博士领导。

In this interview, she talks about the need for a reliable tooth replacement solution that works well in challenging cases too and offers long-term performance..

在这次采访中，她谈到需要一种可靠的牙齿替代解决方案，这种解决方案在具有挑战性的情况下也能很好地工作，并提供长期的表现。。

Dr Karapataki, congratulations on the publication of your long-term study on two-piece Patent implants published in the International Journal of Oral and Maxillofacial Implants, one of the highest-impact journals in the field. What surprised you the most about the results?

Karapataki博士，祝贺您在该领域影响最大的期刊之一《国际口腔颌面植入杂志》上发表了关于两片专利植入物的长期研究。结果让你最惊讶的是什么？

Everyday dentistry can be very challenging. In my private dental clinic in Athens, I treat every patient who walks through my practice doors. Patients in need of tooth replacement often present with typical risk factors for dental implant treatment, either local ones such as periodontitis or general health conditions such as osteoporosis or diabetes.

日常牙科可能非常具有挑战性。在雅典我的私人牙科诊所里，我为每一个走过我诊所门的病人进行治疗。需要更换牙齿的患者通常会出现牙种植治疗的典型危险因素，无论是局部因素，如牙周炎，还是一般健康状况，如骨质疏松症或糖尿病。

These patients are usually considered far from ideal candidates for dental implant treatment. They are often under medication, have poor oral hygiene or are heavy smokers. Also, compliance—which is crucial for the longevity of implants—is often poor among these patients..

这些患者通常被认为远不是种植牙治疗的理想候选者。他们经常服用药物，口腔卫生不佳或吸烟者很多。此外，对于植入物的寿命至关重要的依从性在这些患者中往往很差。。

Furthermore, even in “ideal” patients, we, as practitioners, cannot guarantee that their state of health will remain the same in the future. For instance, I have had patients who developed cancer and underwent intense medical treatments. These patients had dental implants, and the challenge was to follow them up appropriately.

此外，即使在“理想”患者中，我们作为从业者也不能保证他们的健康状况在未来保持不变。例如，我有一些患者患上了癌症，并接受了严格的治疗。这些患者有牙种植体，面临的挑战是对他们进行适当的随访。

My long-term study included exactly the sorts of patients that I treat daily in my practice..

我的长期研究完全包括了我在实践中每天治疗的患者。。

What surprised me the most was that, even in these challenging cases, the two-piece Patent implants investigated yielded remarkable results. The most remarkable result was that, even after 12 years, no instances of peri-implantitis and a very low number of cases of peri-implant mucositis were found..

最令我惊讶的是，即使在这些具有挑战性的案例中，所研究的两件式专利植入物也取得了显著的效果。最显着的结果是，即使在12年后，也没有发现种植体周围炎的病例，并且发现种植体周围粘膜炎的病例数量非常少。。

In 2021, Dr Sofia Karapataki received the “Most Influential Female in Dentistry—Greece” award from the Global Health and Pharma magazine. (Image: OEMUS MEDIA)

2021年，Sofia Karapataki博士获得了《全球健康与制药杂志》颁发的“希腊牙科最具影响力女性”奖。（图片：OEMUS MEDIA）

Why did you choose Patent as your implant system?

为什么选择专利作为植入系统？

I was determined to find a tooth replacement solution that works in the challenging cases I have mentioned. It was difficult to find a system that was supported by extensive research. To my surprise, I found that fewer and fewer implant systems today undergo comprehensive scientific evaluation before they are introduced to the market.

我决心找到一种在我提到的具有挑战性的情况下有效的牙齿替代解决方案。很难找到一个得到广泛研究支持的系统。令我惊讶的是，我发现如今越来越少的植入系统在引入市场之前接受了全面的科学评估。

This means less predictability and a higher risk for patients and surgeons. In contrast, Patent has been extensively investigated in scientific studies, including in long-term clinical trials..

这意味着患者和外科医生的可预测性较低，风险较高。相比之下，专利已在科学研究中进行了广泛调查，包括在长期临床试验中。。

Following up on the Patent implants you placed, what did you observe?

在你植入专利植入物后，你观察到了什么？

I observed stable marginal bone levels and healthy soft tissue completely free of inflammation during annual recalls, even in patients with pre-existing health conditions and poor oral hygiene. For instance, I observed cases where the bone and soft tissue around a Patent implant remained unaffected by chronic tissue inflammation around both adjacent teeth.

在年度召回期间，我观察到稳定的边缘骨骼水平和健康的软组织完全没有炎症，即使是已经存在健康状况和口腔卫生不良的患者。例如，我观察到专利植入物周围的骨骼和软组织不受相邻牙齿周围慢性组织炎症的影响。

This was a sensational finding!.

这是一个耸人听闻的发现！。

How can this be explained?

这怎么解释？

The key to success lies in the strong and intimate soft-tissue adhesion to the transmucosal surface of the Patent implant, serving as an ideal defence barrier against bacteria. Additionally, fast healing has been observed around Patent dental implants in studies, ensuring greater safety in compromised patients, who typically show a pattern of slower healing..

成功的关键在于牢固而亲密的软组织粘附在专利植入物的跨粘膜表面，作为抵抗细菌的理想防御屏障。此外，在研究中观察到专利牙植入物周围的快速愈合，确保了受损患者的更大安全性，这些患者通常表现出较慢的愈合模式。。

Why did you initiate this long-term study on two-piece Patent implants?

你为什么要开始这项关于两件式专利植入物的长期研究？

I found it remarkable how well this implant system performed in the patients that I encountered daily in my practice. Therefore, I wanted to validate my clinical experience and analyse the performance of this tooth replacement solution in a scientific setting. The study results speak for themselves: no peri-implantitis after up to 12 years, only 7.7% peri-implant mucositis at the patient level, survival and success rates of 100%, and only minor prosthetic complications..

我发现这种植入系统在我每天的实践中遇到的患者中表现得非常好。因此，我想验证我的临床经验，并在科学环境中分析这种牙齿替代解决方案的性能。研究结果不言而喻：长达12年后没有种植体周围炎，患者水平只有7.7%的种植体周围粘膜炎，生存率和成功率为100%，只有轻微的假体并发症。。

What is your conclusion based on these long-term results?

根据这些长期结果，你的结论是什么？

If Patent performs exceptionally well over the long term in my pool of compromised patients, as both the study findings and my clinical experience prove, then trust me, it will perform as reliably in the general patient population! The Patent Dental Implant System is the best choice for every patient and dentist..

如果像研究结果和我的临床经验所证明的那样，专利在我的受损患者群体中长期表现异常良好，那么相信我，它在普通患者群体中的表现将同样可靠！专利牙科植入系统是每位患者和牙医的最佳选择。。

Dental implant

牙科植入物

Dental research

牙科研究

Peri-implantitis

种植体周围炎

Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name *

保留回复取消回复您的电子邮件地址将不会发布。必填字段标记为*注释名称*

Email *

电子邮件*

Website

网站

News

新闻

Mon. 26. February 2024

周一。2024年2月26日

Long-term study finds no peri‑implantitis around two‑piece Patent implants

长期研究发现两片专利植入物周围没有种植体周围炎

ZURICH, Switzerland: At a press event in Zurich on 15 February, Dr Roland Glauser, a Zurich-based expert in comprehensive implantology, highlighted ...

瑞士苏黎世：2月15日，在苏黎世的一次新闻发布会上，总部位于苏黎世的综合植入学专家罗兰·格拉瑟博士强调。。。

News

新闻

Wed. 6. December 2023

周三。2023年12月

Guided Biofilm Therapy is an absolute patient favourite

引导生物膜疗法绝对是患者的最爱

NYON, Switzerland: Those who prioritise their overall health also understand the importance of oral health and consistently seek professional prophylaxis. ...

瑞士尼翁：那些优先考虑整体健康的人也了解口腔健康的重要性，并不断寻求专业预防。。。

News

新闻

Thu. 30. November 2023

清华大学。2023年11月30日

The future of regenerative dentistry: “Cells alone are not proving to be enough to provide lasting, curative treatments”

再生牙科的未来：“单凭细胞还不足以提供持久的治疗方法”

Being able to not only customise treatment plans but provide bioidentical implants to patients is a dream that may not be too far off considering the ...

不仅能够定制治疗计划，而且能够为患者提供生物完全相同的植入物是一个梦想，考虑到。。。

News

新闻

Tue. 31. October 2023

BioHorizons Camlog and Amann Girrbach announce cooperation in implant prosthetics

BioHorizons Camlog和Amann Girrbach宣布合作种植修复

BASEL, Switzerland/KOBLACH, Austria: BioHorizons Camlog and Amann Girrbach recently joined forces and have announced their collaboration in the field of ...

瑞士巴塞尔/奥地利科布拉赫：BioHorizons Camlog和Amann Girrbach最近联手，并宣布他们在……领域的合作。。。

News

新闻

Mon. 3. July 2023

周一。2023年7月

First long-term study on two-piece zirconia implants published

首次发表两片式氧化锆植入物的长期研究

ALTENDORF, Switzerland: The first long-term study on two-piece zirconia dental implants has been published and addresses a major research gap. Over a period...

瑞士阿尔滕多夫：第一项关于两片式氧化锆牙科植入物的长期研究已经发表，解决了一个重大的研究差距。在一段时间内。。。

News

新闻

Mon. 4. March 2024

周一。2024年3月

Laser-assisted protocol for the treatment of peri-implantitis: A long-term retrospective case series

激光辅助治疗种植体周围炎的长期回顾性病例系列

Pulsed Nd:YAG dental lasers are surgical tools used to obtain specific surgical objectives as defined in the LANAP (laser-assisted new attachment procedure)...

脉冲Nd:YAG牙科激光器是用于获得LANAP（激光辅助新附着程序）中定义的特定手术目标的手术工具。。。

Education

教育

Live webinar

现场网络研讨会

Wed. 20 March 2024 8:00 pm EST (New York)

一个赌注。2024年3月20日美国东部时间晚上8:00（纽约）

Mastering dental photography: Elevate your practice with compelling images

掌握牙科摄影：通过引人注目的图像提升你的实践

Dr. Mahfuz Rahman

Mahfuz Rahman博士

立即注册

1CE

1CE公司

Live webinar

现场网络研讨会

Fri. 22 March 202411:00 am EST (New York)

星期五美国东部时间2024年3月22日上午11:00（纽约）

Synergistic workflows: Uniting clinicians and lab technicians

协同工作流程：联合临床医生和实验室技术人员

Prof. Hani Tohme

Hani Tohme教授

立即注册

Live webinar

现场网络研讨会

Mon. 25 March 2024 1:00 pm EST (New York)

我的。2024年3月25日美国东部时间下午1:00（纽约）

Sinnvolle Integration von Alignern in der nicht invasiven Comprehensive Dentistry

矫正器在非侵入性综合牙科中的有用集成

Dr. Michel Vock

Michel Vock博士

立即注册

Live webinar

现场网络研讨会

Tue. 26 March 2024 2:00 pm EST (New York)

杀人。2024年3月26日美国东部时间下午2:00（纽约）

Neodent Discovery: Avoiding complication and achieving successful outcomes through advanced diagnosis and treatment planning—free-hand vs guided protocols

Neodent发现：通过先进的诊断和治疗计划，避免并发症并取得成功，徒手与引导方案

Dr. Scott Ganz DMD

Scott Ganz博士DMD

立即注册

1CE

1CE公司

Live webinar

现场网络研讨会

Tue. 26 March 2024 4:00 pm EST (New York)

杀人。2024年3月26日美国东部时间下午4:00（纽约）

The use of sticky xenograft in full-arch restorations and complex cases

粘性异种移植物在全牙弓修复和复杂病例中的应用